Axogen, Inc. (AXGN) is a electromedical & electrotherapeutic apparatus company incorporated in MN, listed on the Nasdaq. With a market capitalization of $1.5 billion, Axogen, Inc. is a small-cap company. The stock currently trades at $30.65, down 3.40% today, with a 52-week range of $9.22–$36.00. The company trades at a forward P/E of 41.6x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.34 | $-0.34 | -47.8% | |
| 2024 | $-0.23 | $-0.23 | +54.9% | |
| 2023 | $-0.51 | $-0.51 | +26.1% | |
| 2022 | $-0.69 | $-0.69 | -6.2% | |
| 2021 | $-0.65 | $-0.65 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-24 | 0000805928-26-000031 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0000805928-25-000017 | SEC ↗ |
| 2023-12-31 | 2024-03-05 | 0000805928-24-000028 | SEC ↗ |
| 2022-12-31 | 2023-03-14 | 0000805928-23-000020 | SEC ↗ |
| 2021-12-31 | 2022-02-25 | 0000805928-22-000026 | SEC ↗ |
| 2020-12-31 | 2021-03-01 | 0000805928-21-000044 | SEC ↗ |
| 2019-12-31 | 2020-02-24 | 0001558370-20-001238 | SEC ↗ |
| 2018-12-31 | 2019-02-26 | 0001558370-19-001095 | SEC ↗ |
| 2017-12-31 | 2018-02-28 | 0001558370-18-001268 | SEC ↗ |
| 2016-12-31 | 2017-03-01 | 0001558370-17-001241 | SEC ↗ |
| 2015-12-31 | 2016-02-29 | 0001558370-16-003691 | SEC ↗ |
| 2014-12-31 | 2015-03-05 | 0001104659-15-017126 | SEC ↗ |
| 2013-12-31 | 2014-03-06 | 0001104659-14-017051 | SEC ↗ |